Cardiac Conduction System Disease

"Cardiac Conduction System Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Diseases characterized by pathological irregularities in the HEART CONDUCTION SYSTEM. They may be associated with other heart diseases and syndromes (e.g., BRUGADA SYNDROME; NEUROMUSCULAR DISEASE, HEART BLOCKS), isolated or may result from injuries. You can have a conduction disorder without having an arrhythmia, but some arrhythmias arise from conduction disorders. OMIM: 601144.

Descriptor ID	D000075224
MeSH Number(s)	C14.280.123
Concept/Terms	Cardiac Conduction System Disease Cardiac Conduction System Disease Cardiac Conduction System Diseases Cardiac Conduction Defects Cardiac Conduction Defects Conduction Defect, Cardiac Defect, Cardiac Conduction Cardiac Conduction Defect

Below are MeSH descriptors whose meaning is more general than "Cardiac Conduction System Disease".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Cardiac Conduction System Disease [C14.280.123]

Below are MeSH descriptors whose meaning is more specific than "Cardiac Conduction System Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiac Conduction System Disease" by people in this website by year, and whether "Cardiac Conduction System Disease" was a major or minor topic of these publications.

Bar chart showing 11 publications over 6 distinct years, with a maximum of 3 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2013	0	2	2
2015	0	3	3
2016	0	2	2
2018	1	0	1
2022	0	2	2
2024	0	1	1

Below are the most recent publications written about "Cardiac Conduction System Disease" by people in Profiles.

Kantharia BK, Knight B, L?vy S, Cappato R. Journal of Cardiovascular Electrophysiology special section: The European Cardiac Arrhythmia Society 2023 meeting. J Cardiovasc Electrophysiol. 2024 Mar; 35(3):520-521.

View in: PubMed
Mehta NA, Saqi B, Sabzwari SRA, Gupta R, Vyas A, Gordon J, Cossu S, Nazir T, Freudenberger R, Bozorgnia B. Durability of left bundle branch area pacing. J Cardiovasc Electrophysiol. 2022 07; 33(7):1529-1536.

View in: PubMed
L?vy S, Steinbeck G, Santini L, Nabauer M, Penela D, Kantharia BK, Saksena S, Cappato R. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Card Electrophysiol. 2022 Oct; 65(1):287-326.

View in: PubMed
Di Diego JM, Antzelevitch C. J wave syndromes as a cause of malignant cardiac arrhythmias. Pacing Clin Electrophysiol. 2018 07; 41(7):684-699.

View in: PubMed
Veltmann C, Barajas-Martinez H, Wolpert C, Borggrefe M, Schimpf R, Pfeiffer R, C?ceres G, Burashnikov E, Antzelevitch C, Hu D. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect. J Am Heart Assoc. 2016 07 05; 5(7).

View in: PubMed
Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley-Davies A, Satchithananda D, Nolan J, Myint PK, Buchan I, Loke YK, Mamas MA. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016 May; 102(9):672-80.

View in: PubMed
Kosiuk J, Dinov B, Kornej J, Acou WJ, Sch?nbauer R, Fiedler L, Buchta P, Myrda K, Gasior M, Polonski L, Kircher S, Arya A, Sommer P, Bollmann A, Hindricks G, Rolf S. Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score. Heart Rhythm. 2015 Nov; 12(11):2207-12.

View in: PubMed
Antzelevitch C, Yan GX. J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm. 2015 Aug; 12(8):1852-66.

View in: PubMed
Heller S, Darp? B, Mitchell MI, Linnebjerg H, Leishman DJ, Mehrotra N, Zhu H, Koerner J, Fiszman ML, Balakrishnan S, Xiao S, Todaro TG, Hensley I, Guth BD, Michelson EL, Sager P. Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium. Am Heart J. 2015 Jul; 170(1):23-35.

View in: PubMed
Koncz I, Gurabi Z, Patocskai B, Panama BK, Sz?l T, Hu D, Barajas-Mart?nez H, Antzelevitch C. Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome. J Mol Cell Cardiol. 2014 Mar; 68:20-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement